Inhibition of nuclear factor κb activation and cyclooxygenase-2 expression by aqueous extracts of hispanic medicinal herbs

Journal of Medicinal Food

Volumn 13, Issue 4, 2010, Pages 888-895

  Orlando, Robert A ^a   Gonzales, Amanda M ^a   Hunsaker, Lucy A ^a   Franco, Carolina R ^a   Royer, Robert E ^a   Vander Jagt, David L ^a   Vander Jagt, Dorothy J ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

anti inflammatory agent; cyclooxygenase 2; nuclear factor jB; signaling; tea

Indexed keywords

AMERANTHUS EXTRACT; ANEMOPSIS CALIFORNICA EXTRACT; ARTEMISIA FRANSERIOIDES EXTRACT; CHENOPODIUM AMBROSIOIDES EXTRACT; CINCHONA EXTRACT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EPHEDRA VIRIDIS EXTRACT; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JUGLANS EXTRACT; LAUREL NOBILIS EXTRACT; LAVANDULA EXTRACT; LINUM LEWISSII EXTRACT; MELIILOTUS ALBA EXTRACT; MENTHA SPICATA EXTRACT; OCIMUM BASILICUM EXTRACT; PLANT EXTRACT; PROSTAGLANDIN E2; PRUNUS EXTRACT; ROSA DE CASTILLO EXTRACT; ROSMARINUS OFFICINALIS EXTRACT; RUMEX HYMENOSEPALUS EXTRACT; SAFFLOWER EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMERANTHUS; ANEMOPSIS CALIFORNICA; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTEMISIA FRANSERIOIDES; ARTICLE; BASIL; CHENOPODIUM AMBROSIOIDES; CINCHONA; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG SCREENING; DRUG STABILITY; ENZYME INACTIVATION; EPHEDRA VIRIDIS; FRACTIONATION; HERB; HISPANIC; IC 50; LAUREL NOBILIS; LAVENDER; LINUM LEWISSII; MEDICINAL PLANT; MELIILOTUS ALBA; MENTHA SPICATA; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRUNUS; REAL TIME POLYMERASE CHAIN REACTION; ROSA DE CASTILLO; ROSEMARY; RUMEX HYMENOSEPALUS; SAFFLOWER; SIGNAL TRANSDUCTION; STANDARDIZATION; WALNUT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CYCLOOXYGENASE 2; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISPANIC AMERICANS; HUMANS; INFLAMMATION; NF-KAPPA B; PLANT EXTRACTS; PLANTS, MEDICINAL;

MURINAE;

EID: 77955188365     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.1128     Document Type: Article

References (42)

1. Borer JS, Simon LS: Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. Arthritis Res Ther 2005;7(Suppl 4):S14-S22.
2. Hermann M, Ruschitzka F: Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Ann Med 2007;39:18-27.
3. Hinz B, Renner B, Brune K: Drug insight: cyclo-oxygenase-2 inhibitors\a critical appraisal. Nat Clin Pract Rheumatol 2007;3:552-560; quiz 551 following 589.
4. White W: Cardiovascular risk, hypertension, and NSAIDs. Curr Pain Headache Rep 2007;11:428-435. (Pubitemid 350226351)
5. Meyer S, Meyer F: Traditional Herbs de Nuevo Mexico: A Complete Booklet of Traditional Uses and Beliefs of New Mexican Herbs. Rio Grande Herb Company, Albuquerque, NM, 1994.
6. Gilmore TD: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680-6684.
7. Karin M, Yamamoto Y, Wang QM: The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004;3:17-26.
8. Nam NH: Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 2006;6:945-951.
9. Banerjee S, Bueso-Ramos C, Aggarwal BB: Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogen-esis in rats by resveratrol: role of nuclear factor-kappaB, cycloox-ygenase 2, and matrix metalloprotease 9. Cancer Res 2002;62: 4945-4954.
10. Bhardwaj A, Sethi G, Vadhan-Raj S, et al.: Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007;109:2293-2302.
11. Estrov Z, Shishodia S, Faderl S, et al.: Resveratrol blocks in-terleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102:987-995.
12. Heynekamp JJ, Weber WM, Hunsaker LA, et al.: Substituted trans-stilbenes, including analogues of the natural product re-sveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. J Med Chem 2006;49:7182-7189.
13. VanderJagt TJ, Ghattas R, VanderJagt DJ, Crossey M, Glew RH: Comparison of the total antioxidant content of 30 widely used medicinal plants of New Mexico. Life Sci 2002;70:1035-1040.
14. Bent S: Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 2008;23:854-859.
15. Skalli S, Zaid A, Soulaymani R: Drug interactions with herbal medicines. Ther Drug Monit 2007;29:679-686.
16. Shan JJ, Rodgers K, Lai CT, Sutherland SK: Challenges in natural health product research: the importance of standardization. Proc West Pharmacol Soc 2007;50:24-30.
17. Fiorini C, Fouraste I, David B, Bessiere J: Composition of the flower, leaf and stem essential oils from L. nobilis. Flavour Fragrance 1997;12:91-93.
18. Putievsky E, Ravid U, Snir N, Sanderovich D: The essential oils from cultivated bay laurel. Isr J Bot 1984;33:47-52.
19. De Marino S, Borbone N, Zollo F, et al.: Megastigmane and phenolic components from Laurus nobilis L. leaves and their inhibitory effects on nitric oxide production. J Agric Food Chem 2004;52:7525-7531.
20. El-Feraly F, Benigni D: Sesquiterpene lactones of Laurus nobilis leaves. J Nat Prod 1980;43:527-531.
21. Novak M: A monoterpene alcohol from Laurus nobilis leaves. Phytochemistry 1985;24:858-861.
22. Pech B, Bruneton J: Alkaloids of Laurus nobilis. J Nat Prod 1982;45:560-563.
23. Matsuda H, Shimoda H, Ninomiya K, Yoshikawa M: Inhibitory mechanism of costunolide, a sesquiterpene lactone isolated from Laurus nobilis, on blood-ethanol elevation in rats: involvement of inhibition of gastric emptying and increase in gastric juice secretion. Alcohol Alcohol 2002;37:121-127.
24. Komiya T, Yamada Y, Moteki H, et al.: Hot water soluble sesquiterpenes [anhydroperoxy-costunolide and 3-oxoeudesma-1,4(15),11(13)triene-12,6alpha- olide] isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia cells. Oncol Rep 2004;11:85-88.
25. Uchiyama N, Matsunaga K, Kiuchi F, et al.: Trypanocidal ter-penoids from Laurus nobilis L. Chem Pharm Bull (Tokyo) 2002;50:1514-1516.
26. Sayyah M, Valizadeh J, Kamalinejad M: Anticonvulsant activity of the leaf essential oil of Laurus nobilis against pentylenete-trazole-and maximal electroshock-induced seizures. Phytome-dicine 2002;9:212-216.
27. Dadalioglu I, Evrendilek GA: Chemical compositions and antibacterial effects of essential oils of Turkish oregano (Origanum minutiflorum), bay laurel (Laurus nobilis), Spanish lavender (Lavandula stoechas L.), and fennel (Foeniculum vulgare) on common foodborne pathogens. J Agric Food Chem 2004;52: 8255-8260.
28. Sayyah M, Saroukhani G, Peirovi A, Kamalinejad M: Analgesic and anti-inflammatory activity of the leaf essential oil of Laurus nobilis Linn. Phytother Res 2003;17:733-736.
29. Matsuda H, Kagerura T, Toguchida I, et al.: Inhibitory effects of sesquiterpenes from bay leaf on nitric oxide production in lipo-polysaccharide- activated macrophages: structure requirement and role of heat shock protein induction. Life Sci 2000;66:2151-2157.
30. Daels-Rakotoarison DA, Gressier B, Trotin F, et al.: Effects of Rosa canina fruit extract on neutrophil respiratory burst. Phytother Res 2002;16:157-161.
31. Larsen E, Kharazmi A, Christensen LP, Christensen SB: An antiinflammatory galactolipid from rose hip (Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitro. J Nat Prod 2003;66:994-995.
32. Nowak R: Determination of ellagic acid in pseudofruits of some species of roses. Acta Pol Pharm 2006;63:289-292. (Pubitemid 351356830)
33. Jager AK, Eldeen IM, van Staden J: COX-1 and\2 activity of rose hip. Phytother Res 2007;21:1251-1252.
34. Winther K, Rein E, Kharazmi A: The anti-inflammatory properties of rose-hip. Inflammopharmacology 1999;7:63-68.
35. Yi O, Jovel EM, Towers GH, Wahbe TR, Cho D: Antioxidant and antimicrobial activities of native Rosa sp. from British Columbia, Canada. Int J Food Sci Nutr 2007;58:178-189.
36. Dunphy PJ: Location and biosynthesis of monoterpenyl fatty acyl esters in rose petals. Phytochemistry 2006;67:1110-1119.
37. Basim E, Basim H: Antibacterial activity of Rosa damascena essential oil. Fitoterapia 2003;74:394-396.
38. Schiber A, Mihalev K, Berardini N, Mollov P, Carle R: Flavonol glycosides from distilled petals of Rosa damascena Mill. Z Naturforsch [C] 2005;60:379-384.
39. Gilbert B, Alves LF: Synergy in plant medicines. Curr Med Chem 2003;10:13-20.
40. Spelman K: Philosophy in phytopharmacology: Ockham's Razor versus synergy. J Herb Pharmacother 2005;5:31-47.
41. Spinella M: The importance of pharmacological synergy in psychoactive herbal medicines. Altern Med Rev 2002;7:130-137.
42. Williamson EM: Synergy and other interactions in phytomedi-cines. Phytomedicine 2001;8:401-409.